Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2026-01-20 @ 6:42 AM
Study NCT ID:
NCT05267366
Status:
UNKNOWN
Last Update Posted:
2023-03-29
First Post:
2022-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC
Sponsor:
Qingdao Central Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
QDCH2022-02-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None